Black Diamond co-founders David Epstein (L) and Elizabeth Buck

Black Di­a­mond lays off 30% of its work­force and culls a drug from its 'Mas­terKey' chest

With every round of lay­offs, the dol­drums of the biotech bear mar­ket get ever dark­er and more de­press­ing. Black Di­a­mond Ther­a­peu­tics is the lat­est to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.